IDNA News and Press, iShares Genomics Immunology and Healthcare From 09/13/21

A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. Focus on IDNA. A list of cheap stocks. For further details see: IDNA: Healthcare Dashboard For September

Price pressures are most concentrated in those sectors reporting the greatest constraints. Output consequently fell in China as well as a number of other smaller Asia-Pacific economies, and growth slowed in the US and Europe. The constraints on production caused by a lack of input...

Defensive stocks are often misunderstood. In recent years, even when they have delivered strong and steady earnings, returns have disappointed. After a period of underperformance for defensives, a broadening market can represent real opportunity. Beyond utilities, we believe that ...

A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. Focus on IDNA. A list of cheap stocks. For further details see: IDNA And Healthcare Dashboard For July

IDNA enables investors to benefit from advancements and commercialization opportunities of the genomics field. Compared to ARKG, this is more of a pure-play gene ETF and is also less volatile. On the cautionary side, with the progress being done, especially in CRISPR, more media f...

Emerging technologies like gene editing, gene therapy, artificial intelligence AI, and next generation sequencing NGS should continue to improve clinical trial success rates, increasing the percentage of drug candidates that commercialize successfully. NGS, AI, CRISPR, and other gene ...

COVID-19 has only revealed a small glimpse of the possibilities offered by genomics, a field which is leading us towards predictive and personalized health care. However, ARKG goes beyond just genomic sequencing and editing. Despite suffering from more short-term volatility when c...

Much of last week’s economic focus was on the inflation report. Inflation was indeed pretty hot year over year, but that wasn’t unexpected. With CPI printing at 5% year over year, bond yields fell. But these are small moves, and the trend for rates is still up for now. ...

From a consumer perspective, the consumer is actually now demanding a focus on environmental, social, governance factors. If public expectations for inflation do rise, that is going to be a change from years past. There’s going to be an opportunity to make medical progress ...

iShares Genomics Immunology and Healthcare ETF (IDNA) - $0.0521.30-Day SEC Yield of 0.09% as of May 28.Payable Jun 16; for shareholders of record Jun 11; ex-div Jun 10. For further details see: iShares Genomics Immunology and Healthcare ETF declares semi-annual distribution of $0.0521 ...